More Recce Pharmaceuticals Ltd. news
Recce Pharmaceuticals Ltd.ASX: RCE

Response to ASX Appendix 4C Query

Aug 16, 2019 at 7:30 AM EDT · Issued by Recce Pharmaceuticals Ltd.

Filed with ASX · Aug 16, 2019 at 7:30 AM EDT

On 6ix: 6ix.com/news/response-to-asx-appendix-4c-query-27

Recce Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Recce Pharmaceuticals Ltd. on 6ix

Story so far

  • Response to ASX Price QuerySep 18, 2017

Earlier from Recce Pharmaceuticals

  • Key Family 2 Patent Granted in Europe for RECCE AntibioticsAug 8, 2019
  • Opening R&D Address at World Antibiotic Resistance CongressJul 31, 2019
  • Appendix 4C and commentaryJul 30, 2019
  • Appointment of Independent Chair and Additional DirectorJul 9, 2019
  • USA Patent Granted for Recces AntibioticsMar 13, 2019

Later from Recce Pharmaceuticals

  • FDA Positive Response for Recce Scaled Manufacture & QualityAug 26, 2019
  • Appendix 4E - Preliminary Final ReportAug 30, 2019
  • Funding UpdateSep 11, 2019
  • Key Family 2 Patent Granted in Japan for RECCE AntibioticsSep 20, 2019
  • Recce Completes Raising of $6.76 millionOct 9, 2019
All Recce Pharmaceuticals news releases↗

Follow Recce Pharmaceuticals into a list and get an email when it puts out news.

Follow Recce Pharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer